SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NAS: ILMN) today announced that it has acquired Cambridge, U.K.-based BlueGnome Ltd. for an undisclosed sum. BlueGnome, now a wholly owned subsidiary of ...

A novel approach to external quality assessment (EQA) using the Internet mimics the diagnostic situation so that multiple tests can be requested and EQA cases can be ‘tailor made’ to address a ...

Purpose: To evaluate the sensitivity, specificity, advantages, and limitations of multiplex ligation-dependent probe amplification compared with conventional karyotype analysis in the investigation of ...

Throughout the last 50 years, cytogenetic analyses of pretreatment bone marrow and / or blood samples from patients diagnosed with acute myeloid leukemia (AML) revealed a large number of recurring ...

Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Global Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique ...

With an aim to expand in the field of genomic-based diagnostic tools, Illumina Inc. (ILMN), a major developer of life science tools for large-scale genetic analysis, recently acquired UK based ...

Cytocell Ltd. today announced the availability of a new molecular cytogenetic test designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung ...

Reforms at the cytogenetics laboratory at Our Lady's Children's Hospital in Crumlin are important and necessary to meet best practice standards and to minimise risk and optimise patient care, the HSE ...

The sophisticated 'cytogenetic facility' to diagnose various types of blood cancer was added to the list of equipments at Indo American Cancer Institute & Research Centre on Saturday. HYDERABAD: The ...

NEW HAVEN, Conn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS ...